Abbott Laboratories Inc. will pay $3.72 billion to acquire the branded generics business of India’s Piramal Healthcare, as global drugmakers look to boost their presence in emerging markets.
*For more on this story, read the full Reuters article.
Abbott Laboratories Inc. will pay $3.72 billion to acquire the branded generics business of India’s Piramal Healthcare, as global drugmakers look to boost their presence in emerging markets.
*For more on this story, read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99